Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.
Glypican 3 (GPC3) belongs to a family of glycosylphosphatidylinositol-anchored, cell-surface heparan sulfate proteoglycans. GPC3 is overexpressed in hepatocellular carcinoma. Loss-of-function mutations of GPC3 result in Simpson-Golabi-Behmel syndrome, an X-linked disorder characterized by overgrowth of multiple organs, including the liver. Our previous study showed that GPC3 plays a negative regulatory role in hepatocyte proliferation, and this effect may involve CD81, a cell membrane tetraspanin. To further investigate GPC3 in vivo, we engineered transgenic (TG) mice overexpressing GPC3 in the liver under the control of the albumin promoter. GPC3 TG mice with hepatocyte-targeted, overexpressed GPC3 developed normally in comparison with their nontransgenic littermates but had a suppressed rate of hepatocyte proliferation and liver regeneration after partial hepatectomy. Moreover, gene array analysis revealed a series of changes in the gene expression profiles in TG mice (both in normal mice and during liver regeneration). In unoperated GPC3 TG mice, there was overexpression of runt related transcription factor 3 (7.6-fold), CCAAT/enhancer binding protein alpha (2.5-fold), GABA A receptor (2.9-fold), and wingless-related MMTV integration site 7B (2.8-fold). There was down-regulation of insulin-like growth factor binding protein 1 (8.4-fold), Rab2 (5.6-fold), beta-catenin (1.7-fold), transforming growth factor beta type I (3.1-fold), nodal (1.8-fold), and yes-associated protein (1.4-fold). Changes after hepatectomy included decreased expression in several cell cycle-related genes.


CONCLUSIONS
Our results indicate that in GPC3 TG mice, hepatocyte overexpression of GPC3 suppresses hepatocyte proliferation and liver regeneration and alters gene expression profiles, and potential cell cycle-related proteins and multiple other pathways are involved and affected.
Liu
Bowen
B
Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Bell
Aaron W
AW
Paranjpe
Shirish
S
Bowen
William C
WC
Khillan
Jaspal S
JS
Luo
Jian-Hua
JH
Mars
Wendy M
WM
Michalopoulos
George K
GK
D000818:Animals; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000378:metabolism; D018797:Cell Cycle Proteins / Q000378:metabolism; D049109:Cell Proliferation; D020869:Gene Expression Profiling; D053673:Glypicans / Q000235:genetics / Q000378:metabolism*; D006498:Hepatectomy; D022781:Hepatocytes / Q000166:cytology* / Q000378:metabolism*; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008115:Liver Regeneration / Q000502:physiology*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal; D011963:Receptors, GABA-A / Q000378:metabolism; D011991:Receptors, Virus / Q000378:metabolism; D053773:Transforming Growth Factor beta1 / Q000378:metabolism; D051176:beta Catenin / Q000378:metabolism; D020693:rab2 GTP-Binding Protein / Q000378:metabolism
D022763:CCAAT-Enhancer-Binding Protein-alpha; D018797:Cell Cycle Proteins; C111417:Fam89b protein, mouse; D053673:Glypicans; D018970:Insulin-Like Growth Factor Binding Protein 1; D011963:Receptors, GABA-A; D011991:Receptors, Virus; D053773:Transforming Growth Factor beta1; D051176:beta Catenin; D020693:rab2 GTP-Binding Protein
Int J Biochem Cell Biol. 2003 Feb;35(2):125-9
12479862
Biochim Biophys Acta. 2002 Dec 19;1573(3):241-6
12417406
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1431-6
20080598
Virchows Arch B Cell Pathol. 1973 Nov 28;14(2):93-103
4203888
Lab Invest. 2006 Dec;86(12):1272-84
17117158
Hepatology. 2009 Sep;50(3):844-51
19575460
J Cell Physiol. 2005 Mar;202(3):707-16
15389569
J Cell Physiol. 2007 Nov;213(2):286-300
17559071
DNA Cell Biol. 1992 Sep;11(7):559-66
1388728
Genes Dev. 2007 Nov 1;21(21):2747-61
17974916
Exp Gerontol. 1976;11(5-6):193-203
1021420
Hepatology. 2004 Apr;39(4):1056-65
15057910
Exp Cell Res. 2010 Jan 15;316(2):149-57
19800882
Glycobiology. 2001 Mar;11(3):19R-23R
11320054
Exp Cell Res. 1967 Dec;48(3):518-28
6082326
Mol Cell Biol. 1990 Aug;10(8):4007-15
1695320
Gastroenterology. 1993 Jan;104(1):217-21
8419244
Science. 1997 Apr 4;276(5309):60-6
9082986
Am J Physiol Renal Physiol. 2003 Jun;284(6):F1216-25
12569082
J Biol Chem. 1996 Sep 6;271(36):22262-70
8703043
Am J Pathol. 2009 Aug;175(2):717-24
19574424
J Cell Biol. 1999 Jul 12;146(1):255-64
10402475
Am J Surg. 1998 Mar;175(3):221-5; discussion 225-6
9560124
Hepatology. 2007 Jan;45(1):195-204
17187422
Cell Cycle. 2008 Sep 15;7(18):2787-90
18787398
Hepatology. 2006 Oct;44(4):1012-24
17006932
Annu Rev Immunol. 1998;16:89-109
9597125
J Clin Invest. 1995 Sep;96(3):1351-65
7657810
Dev Dyn. 1998 Dec;213(4):431-9
9853964
Mech Ageing Dev. 1986 Oct;36(2):125-31
3784626
Histol Histopathol. 2008 Nov;23(11):1333-40
18785116
Cell Cycle. 2008 Jul 15;7(14):2215-24
18635970
Am J Med Genet. 1996 Dec 11;66(2):227-34
8958336